| Introduction |
 Recurring Zoom Link |
|
|
 References |
|
|
 Course Orientation |
Dr. Leonila Estole-Casanova |
|
| Principles of Pharmacodynamics and Pharmacokinetics |
(A) Historical perspectives | Dr. Cleotilde H. How |
Dr. Cleotilde H. How |
|
(B) Pharmacokinetics: The Dynamics of Drug Absorption, Distribution, Metabolism and Elimination | Dr. Herbie H. Ho |
Dr. Herbert Ho |
|
(C) Pharmacodynamics: Molecular mechanisms of Drug action | Dr. Maria Concepcion C. Sison |
Dr. Maria Concepcion C. Sison |
|
(C) EXERCISE: Molecular mechanisms of Drug action | Dr. Maria Concepcion C. Sison |
Dr. Maria Concepcion C. Sison |
|
(D) Principles of Clinical Pharmacology and Therapeutics | | Dr. Maria Concepcion C. Sison |
Dr. Maria Concepcion C. Sison |
|
(E) Drug Development: The Quest or the Perfect Drug | Dr. Raymond V. Oliva |
Dr. Raymond V. Oliva |
|
(F) Safety Pharmacology: The Challenges of Adverse Drug Reactions | Dr. Lynn Crisanta R. Panganiban |
Dr. Lynn Crisanta R. Panganiban
Learning Objectives
At the end of this activity, the students will be able to:
- Distinguish and give examples of the different types of adverse events;
- Discuss strategies to manage and prevent adverse drug events;
- Explain the importance of medication safety;
|
|
(G) Pharmacogenetics: The Key to Personalized Medicine | Dr. Irma R. Makalinao |
Dr. Irma R. Makalinao |
|
| Autonomic Nervous System Pharmacology |
(H) Cholinergic Pharmacology | Dr. Jose Paciano T. Reyes |
Dr. Jose Paciano T. Reyes |
|
(I) Adrenergic Pharmacology | Dr. Maria Concepcion C. Sison |
Dr. Maria Concepcion C. Sison |
|
| Organ-System Pharmacology |
(J) Local Anesthetic Pharmacology | Dr. Leonila E. Casanova |
Dr. Leonila E. Casanova |
|
| (L) CNS Pharmacology |
(L) Sedative-hypnotic drugs | Dr. Karl Matthew Sy Su |
Dr. Karl Matthew Sy Su |
|
(L) Anti-seizure drugs | Dr. Karl Matthew Sy Su |
Dr. Karl Matthew Sy Su |
|
(L) Drugs for Parkinsonism | Dr. Karl Matthew Sy Su |
Dr. Karl Matthew Sy Su |
|
(10.4) Anti-psychotic drugs | Dr. Jose Paciano T. Reyes |
Dr. Jose Paciano T. Reyes
|
|
(10.5) Drugs for Analgesia, Chemical dependence & Addiction | Dr. Nerissa M. Dando |
Dr. Nerissa M. Dando
|
|
| (M) Drugs for Inflammation, Immunomodulation and Hematopoiesis |
(M) Drugs for Immunomodulation & Immunosuppresion | Dr. Herbert Ho, MD |
Dr. Herbert Ho, MD |
|
(12.1) Drugs for Inflammation, Fever, Pain and Gout | Dr. Nerissa M. Dando |
Dr. Nerissa M. Dando |
|
(12.3) Hematopoietic Drugs: Growth Factors, Minerals and Vitamins | Maria Stella T. Giron, MD, PhD |
Maria Stella T. Giron, MD, PhD |
|
(12.4) Drugs for Asthma and COPD | Cleotilde H. How, MD |
Cleotilde H. How, MD |
|
| (N) Drugs for the Cardiovascular System |
(N.1) Drugs for Arrhythmia | Richard Henry III P. Tiongco, MD |
Richard Henry III P. Tiongco, MD |
|
(N.2) Drugs for Ischemic Heart Disease | Richard Henry III P. Tiongco, MD |
Richard Henry III P. Tiongco, MD |
|
(11.1) Drugs for Hypertension | Dr. Raymond V. Oliva |
Dr. Raymond V. Oliva
|
|
(11.4) Drugs for Dyslipidemia | Maria Concepcion C. Sison, MD |
Maria Concepcion C. Sison, MD |
|
(11.5) Drugs for Heart Failure | Maria Concepcion C. Sison, MD |
Maria Concepcion C. Sison, MD |
|
| (O) Respiratory Pharmacology |
(P) Endocrine Pharmacology | Cecilia A. Jimeno, MD |
Cecilia A. Jimeno, MD |
|
| (P) Endocrine Pharmacology |
(P) Endocrine Pharmacology | Cecilia A. Jimeno, MD (copy) |
Cecilia A. Jimeno, MD |
Click here to join recurring Zoom Link